HSV-2

image of two race cars neck and neck

Biotech

GSK surrenders HSV vaccine hopes after phase 2 fail

GSK’s attempt to develop the first vaccine for HSV has ended in failure, leaving the race open for the likes of Moderna and BioNTech.

James Waldron Sep 11, 2024 4:21am

concept of job dismissal with puzzle pieces

Oncorus lays off 15% of workforce, drops solid tumor prospect

Nov 30, 2022 10:55am